Published in Biotech Business Week, February 21st, 2005
All of the shares are being sold by Vion Pharmaceuticals, Inc., and the shares are being offered under the company's effective shelf registration statement relating to the possible sale from time to time of the company's securities.
CIBC World Markets Corp. and Leerink Swann & Company are acting as the exclusive placement agents for the offering.
Vion also announced the death of Walter B. Wriston, a member of its board of directors.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.